Skip to main content
SpringerLink
Log in

Lymphoproliferative Syndrome 1 (LPFS1)

  • Living reference work entry
  • First Online:
Genetic Syndromes

  • 26 Accesses

Abstract

N/A

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Bienemann K, Borkhardt A, Klapper W, Oschlies I (2015) High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency. Histopathology 67(5):607–616

    Article  Google Scholar 

  • Felices M, Berg LJ (2008) The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J Immunol 180(5):3007–3018

    Article  CAS  Google Scholar 

  • Ghosh S, Bienemann K, Boztug K, Borkhardt A (2014) Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects. J Clin Immunol 34(8):892–899

    Article  CAS  Google Scholar 

  • Huck K, Feyen O, Niehues T, Ruschendorf F, Hubner N, Laws HJ et al (2009) Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 119(5):1350–1358

    Article  CAS  Google Scholar 

  • Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F et al (2012) Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 26(5):963–971

    Article  CAS  Google Scholar 

  • Mansouri D, Mahdaviani SA, Khalilzadeh S, Mohajerani SA, Hasanzad M, Sadr S et al (2012) IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int Arch Allergy Immunol 158(4):418–422

    Article  CAS  Google Scholar 

  • Stepensky P, Weintraub M, Yanir A, Revel-Vilk S, Krux F, Huck K et al (2011) IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica 96(3):472–476

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Sara Momtazmanesh & Nima Rezaei

  2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Sara Momtazmanesh & Nima Rezaei

  3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Nima Rezaei

Authors
  1. Sara Momtazmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nima Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nima Rezaei .

Editor information

Editors and Affiliations

  1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Momtazmanesh, S., Rezaei, N. (2021). Lymphoproliferative Syndrome 1 (LPFS1). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_71-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66816-1_71-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66816-1

  • Online ISBN: 978-3-319-66816-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation